D2 receptor
20 drugs CNS
4
approved indications
20
Approved Drugs
16
Companies
14
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (16 companies)
✓ All 20 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (14 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Teva 3 drugs
AbbVie 2 drugs
ALKERMES INC 2 drugs
By Therapeutic Area
CNS 17 drugs
Other 3 drugs
Drugs by Company PRO
Teva 3 drugs
ALKERMES INC 2 drugs
XIAMEN LP PHARM CO 1 drug
UNICHEM 1 drug
INDIVIOR 1 drug
OTSUKA PHARM CO LTD 1 drug
INVENTIA 1 drug
SUNOVION PHARMS INC 1 drug
DOUGLAS PHARMS 1 drug
+ 6 more companies
By Therapeutic Area
CNS 17 drugs
OPIPZA, ARIPIPRAZOLE, PERSERIS KIT, SAPHRIS +13 more
Other 3 drugs
BARHEMSYS, DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLOZAPINE
Indications Treated
SchizophreniaAutistic DisorderTourette’s DisorderMajor Depressive DisorderSchizoaffective DisorderHuntington's DiseaseAutismTourette SyndromePostoperative Nausea and VomitingBipolar DisorderParkinson's DiseaseShockBipolar I DisorderMania
All Drugs Targeting D2 receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| OPIPZA | XIAMEN LP PHARM CO | 2024 | 4 | CNS |
| ARIPIPRAZOLE | UNICHEM | 2015 | 3 | CNS |
| PERSERIS KIT | INDIVIOR | 2018 | 3 | CNS |
| SAPHRIS | AbbVie | 2009 | 3 | CNS |
| ABILIFY MAINTENA KIT | OTSUKA PHARM CO LTD | 2013 | 3 | CNS |
| VRAYLAR | AbbVie | 2015 | 2 | CNS |
| PALIPERIDONE | INVENTIA | 2015 | 2 | CNS |
| UZEDY | Teva | 2023 | 2 | CNS |
| LATUDA | SUNOVION PHARMS INC | 2010 | 2 | CNS |
| VERSACLOZ | DOUGLAS PHARMS | 2013 | 2 | CNS |
| ABILIFY ASIMTUFII | OTSUKA | 2023 | 2 | CNS |
| TETRABENAZINE | Teva | 2015 | 1 | CNS |
| ARISTADA INITIO KIT | ALKERMES INC | 2018 | 1 | CNS |
| BARHEMSYS | ACACIA | 2020 | 1 | |
| SECUADO | HISAMITSU | 2019 | 1 | CNS |
| ONAPGO | MDD US | 2025 | 1 | CNS |
| DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | Pfizer | 1983 | 1 | |
| INVEGA HAFYERA | Johnson & Johnson | 2015 | 1 | CNS |
| ARISTADA | ALKERMES INC | 2015 | 1 | CNS |
| CLOZAPINE | Teva | 1996 | - |